I was tormented so far because we have at least nine randomized controlled trials that, because they are not designed with not always the proper question in mind, but because they have this inconsistent study populations and the metrics that they use are different and their outcomes are different, you come across those inconsistent results that give room to interpretation and room to not use or use ICG...
I was tormented so far because we have at least nine randomized controlled trials that, because they are not designed with not always the proper question in mind, but because they have this inconsistent study populations and the metrics that they use are different and their outcomes are different, you come across those inconsistent results that give room to interpretation and room to not use or use ICG. ICG, let’s say. But in 2026, there was a groundbreaking systematic review and meta-analysis public in the Lancet, gastroenterology and hepatology, by the group of Professor Ronan Cahill that actually put a stop to this. They meta-analyzed these nine randomized controlled trials and the evidence now is CLEAR. ICG—the use of ICG does reduce the leak rates in left-sided colorectal intersection. The jury is still out in the right-sided ones. I invite everyone to read that systematic review and meta-analysis and, of course, take their interpretation in the RCTs as well. launching, actually, a trial, a multi-center observational trial, trying to get standardized protocols, reliable metrics, and clinically significant thresholds. So through that, we can real-time CREATE an algorithm, maybe using AI, that actually can quantify the green that we see in front of our eyes. Because the question that constantly is out there is, how much green is green enough?
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.